We are experiencing a service disruption with our phone system. Clients should reach out to customersupport@navisclinical.com with any questions, while we work to resolve the issue.

CORE Steady-State Oral Fluid Testing

Comprehensive Oral Fluid RX Evaluation (CORE) Logo

Increase Your Visibility Into Prescription Adherence With Steady-State Oral Fluid Testing

CORE (Navis Comprehensive Oral Fluid Rx Evaluation®) is the first patient-monitoring tool to use saliva samples to provide insights to providers if medication is present at a level consistent with the prescribed dosing regimen.  

Until CORE, most providers were not able to distinguish between patients taking only some of their medication and patients taking their medications as prescribed, or if there are metabolic or health issues that need more investigation.

Data released in 2023 illustrates the difference between traditional drug testing and CORE testing.*

From a traditional testing perspective, 81.6% of samples tested were classified as positive for the prescribed opioid, meaning the medication was present in the patient’s system at the time of collection.

However, when the same positive samples were tested using CORE, 62.4% that were previously classified as positive were found to be above or below the expected range (at a level consistent with the prescribed dosing regimen.) 19.3% of patients who tested as expected with the traditional test were found to be below the expected range and 43.1% above.

CORE results above or below expected for prescribed medications

What Our Clients Are Saying

Your form has been submitted.

A representative will follow up with you within one business day.